ArticleHead and neck pathology2020
Congenital Granular Cell Epulis: Classic Presentation and Its Differential Diagnosis.
Article in Head and neck pathology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
11 citing papers in PubMed, 29 citations in OpenAlex.
- Congenital granular cell tumor of the lower lip in a newborn: a case report.International journal of surgery case reports · 2026Article
- Multiple Granular Cell Tumors of the New Born: A Case Report and Literature Review.Clinical case reports · 2026Article
- A Clinical Observation Report on Prenatal Management and Postnatal Treatment of Congenital Granular Cell Epulis.Maternal-fetal medicine (Wolters Kluwer Health, Inc.) · 2024Article
- Clinical and pathological analysis of congenital granular cell tumor.Hua xi kou qiang yi xue za zhi = Huaxi kouqiang yixue zazhi = West China journal of stomatology · 2022Article
- Congenital granular cell tumor in a 2-day-old infant-An unusual situation of a dental emergency.Journal of family medicine and primary care · 2022Article
- Congenital granular cell tumor: Report of a case with literature review and differential diagnosis.Clinical case reports · 2022Article
- Prenatal diagnosis and multidisciplinary management: a case report of congenital granular cell epulis and literature review.The Journal of international medical research · 2021Review
- Article
- Multiple congenital granular cell tumours of the maxilla and mandible: a rare case report and review of the literature.Translational pediatrics · 2021Article
- Congenital Granular Cell Tumour - Case Report and Review of Literature.Annals of maxillofacial surgeryArticle
- A Rare Case of CD68-Positive Congenital Granular Cell Epulis.Indian journal of dermatologyArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 2 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Congenital granular cell epulis (CGCE) is an uncommon lesion of unclear pathogenesis. It occurs predominantly in female newborns with a predilection site of the maxillary alveolar ridge. The mass enlarges prenatally but the growth arrests after birth. Histologically, CGCE is characterized by a proliferation of polygonal cells with eosinophilic, granular cytoplasm and eccentric, bland-appearing nuclei. It closely resembles adult granular cell tumor (GCT) microscopically and S-100 immunostain is often helpful in distinguishing the two (S-100-positive in GCT and S-100-negative in CGCE). Clinically, the lesion should also be distinguished from entities such as infantile myofibroma, rhabdomyoma, melanotic neuroectodermal tumor of infancy, peripheral odontogenic fibroma, and neurofibroma. CGCE demonstrates an excellent prognosis and has not been associated with any syndromes/genetic defects or malignant transformation. Clinicians and pathologists should be familiar with this rare entity and its differential diagnosis for accurate diagnosis and management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.